Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kathryn C. Rahlwes, Beatriz R.S. Dias, Priscila C. Campos, Samuel Alvarez-Arguedas & Michael U. Shiloh. (2023) Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence 14:1.
Read now
Read now
Articles from other publishers (4)
Rima Zein-Eddine, Guislaine Refrégier, Jorge Cervantes & Noemí Kaoru Yokobori. (2023) The future of CRISPR in Mycobacterium tuberculosis infection. Journal of Biomedical Science 30:1.
Crossref
Crossref
Qun Wu, Luqing Cui, Yingying Liu, Rongpeng Li, Menghong Dai, Zhenwei Xia & Min Wu. (2022) CRISPR-Cas systems target endogenous genes to impact bacterial physiology and alter mammalian immune responses. Molecular Biomedicine 3:1.
Crossref
Crossref
Rong Yu & Cai Zhang. (2022) miR-124-Antagonist-Loaded Liposomal Nanoparticles Negatively Regulate the Toll-Like Receptor (TLR)-Signaling Pathway in Alveolar Epithelial Cells in Pulmonary Tuberculosis. Journal of Biomaterials and Tissue Engineering 12:12, pages 2343-2351.
Crossref
Crossref
Simeng Hou, Haotian Wu, Si Chen, Xubo Li, Zhenxing Zhang, Yiwen Cheng, Yuanyuan Chen, Meirong He, Qi An, Churiga Man, Li Du, Qiaoling Chen & Fengyang Wang. (2022) Bovine skin fibroblasts mediated immune responses to defend against bovine Acinetobacter baumannii infection. Microbial Pathogenesis 173, pages 105806.
Crossref
Crossref